XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Description of Company and Basis of Presentation (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 27, 2017
Sep. 30, 2018
Mar. 31, 2019
Dec. 31, 2011
Jun. 01, 2018
Percentage of service charge         5.00%
Cash investment $ 13,000,000        
Investment in common stock per share $ 6.60        
Common stock market price premium percentage 92.00%        
Number of warrants issued to purchase shares of common stock 500,000        
Warrants exercise price per share $ 6.60        
Warrant expiration Jan. 26, 2019        
Milestone payments receivable $ 343,000,000 $ 250,000      
EMA [Member]          
Payments for milestone     $ 4,000,000    
FDA [Member]          
Payments for milestone     $ 6,000,000    
Orphazyme A/S [Member]          
Milestone payments receivable       $ 120,000,000